EU approves Genmab's Tepkinly combo for relapsed follicular lymphoma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to EU approves Genmab's Tepkinly combo for relapsed follicular lymphoma
(NASDAQ: GMAB) Delayed: 34.54 +0.14 (0.41%)
Previous Close $34.40    52 Week High $ 
Open $34.28    52 Week Low $ 
Day High $34.77    P/E N/A 
Day Low $34.22    EPS $ 
Volume 2,703,050